Company NPS Pharmaceuticals, Inc.
Equities
US62936P1030
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval | RE |
2015 | NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,581,155 | 108,074,845 ( 99.53 %) | 0 | 99.53 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- Stock
- Company NPS Pharmaceuticals, Inc.